In light of the large number of studies published since the 2004 update of Schizophrenia
Patient Outcomes Research Team psychopharmacological treatment recommendations, we …

Background Whilst the pharmacological profiles and mechanisms of antidepressants are
varied, there are common reasons why they might help people to stop smoking tobacco …

Background Pharmacotherapies for smoking cessation increase the likelihood of achieving
abstinence in a quit attempt. It is plausible that providing support, or, if support is offered …

Interventions for smoking cessation and reduction in individuals with schizophrenia - Tsoi, DT
- 2013 | Cochrane Library Skip to Content Cookies Our site uses cookies to improve your …

Background—Stopping smoking is associated with many important improvements in health
and quality of life. The use of cessation medications is recommended to increase the …

The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

Importance It is estimated that more than half of those with serious mental illness smoke
tobacco regularly. Standard courses of pharmacotherapeutic cessation aids improve short …

The high prevalence of cigarette smoking and tobacco related morbidity and mortality in
people with chronic mental illness is well documented. This review summarizes results from …

Aims The physical health of people with severe mental illness (SMI) is poor. Smoking‐
related illnesses are a major contributor to excess mortality and morbidity. An up‐to‐date …

People with serious mental illness (SMI) have mortality rates 2 to 3 times higher than the
overall US population, largely due to cardiovascular disease. The prevalence of …